Key result
Myeloid-specific NCOR1 deletion reduces myocardial inflammation and improves cardiac function in HFpEF mice.
Why the study?
Inflammatory response is key in HFpEF, but the underlying mechanisms and role of macrophage inflammation remain poorly understood.
Does myeloid cell-specific NCOR1 deletion reduce myocardial inflammation and improve cardiac function in experimental HFpEF?
Does myeloid cell-specific NCOR1 deletion reduce myocardial inflammation and improve cardiac function in experimental HFpEF?
Myeloid cell-specific deletion of NCOR1 reduces myocardial inflammation and improves cardiac function in experimental HFpEF models.
No takes yet. Share an insight, caveat, or question.
No immediate clinical implications in HFpEF; animal data leave NCOR1 macrophage targeting open for human study.
Gorica et al. (2023) studied Heart failure with preserved ejection fraction (HFpEF). Myeloid cell-specific NCOR1 knockout vs. Wild-type/Control was evaluated on Cardiac function and myocardial inflammation. Myeloid cell-specific NCOR1 deletion significantly reduced myocardial inflammation (TNF-a, IL6, IL-1b) and improved cardiac function in a mouse model of HFpEF.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: